Balasa Dinverno & Foltz LLC Johnson & Johnson Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 40,860 shares of JNJ stock, worth $5.96 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

40,860

Previous 41,079 0.53%

Holding current value

$5.96 Million

Previous $7.29 Million 8.46%

% of portfolio

0.42%

Previous 0.46%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$161.33 - $179.52 $35,331 - $39,314	-219 Reduced 0.53%	40,860 $6.68 Million
Q2 2022 Aug 09, 2022	BUY	$168.19 - $186.01 $182,654 - $202,006	1,086 Added 2.72%	41,079 $7.29 Million
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $30,046 - $34,122	-190 Reduced 0.47%	39,993 $7.09 Million
Q4 2021 Jan 26, 2022	SELL	$155.93 - $173.01 $1.16 Million - $1.28 Million	-7,416 Reduced 15.58%	40,183 $6.87 Million
Q3 2021 Oct 26, 2021	BUY	$161.5 - $179.47 $108,366 - $120,424	671 Added 1.43%	47,599 $7.69 Million
Q2 2021 Jul 23, 2021	BUY	$159.48 - $171.07 $637,441 - $683,766	3,997 Added 9.31%	46,928 $7.73 Million
Q1 2021 Apr 29, 2021	BUY	$153.07 - $170.48 $808,668 - $900,645	5,283 Added 14.03%	42,931 $7.06 Million
Q4 2020 Jan 26, 2021	BUY	$137.11 - $157.38 $933,993 - $1.07 Million	6,812 Added 22.09%	37,648 $5.93 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $210,991 - $231,206	1,503 Added 5.12%	30,836 $4.59 Million
Q2 2020 Aug 07, 2020	BUY	$128.81 - $155.51 $73,421 - $88,640	570 Added 1.98%	29,333 $4.13 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $405,994 - $562,525	3,653 Added 14.55%	28,763 $3.77 Million
Q4 2019 Jan 22, 2020	BUY	$127.5 - $146.44 $139,102 - $159,766	1,091 Added 4.54%	25,110 $3.66 Million
Q3 2019 Nov 06, 2019	SELL	$126.95 - $142.14 $116,413 - $130,342	-917 Reduced 3.68%	24,019 $3.11 Million
Q2 2019 Aug 07, 2019	BUY	$131.15 - $144.24 $66,886 - $73,562	510 Added 2.09%	24,936 $3.47 Million
Q1 2019 May 10, 2019	SELL	$125.72 - $139.79 $33,190 - $36,904	-264 Reduced 1.07%	24,426 $3.42 Million
Q4 2018 Feb 04, 2019	BUY	$122.84 - $147.84 $25,182 - $30,307	205 Added 0.84%	24,690 $3.19 Million
Q3 2018 Oct 24, 2018	BUY	$121.58 - $142.88 $22,857 - $26,861	188 Added 0.77%	24,485 $3.38 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $288,470 - $318,332	-2,416 Reduced 9.04%	24,297 $2.95 Million
Q1 2018 Apr 23, 2018	SELL	$125.1 - $148.14 $252,952 - $299,539	-2,022 Reduced 7.04%	26,713 $3.42 Million
Q4 2017 Feb 05, 2018	SELL	$131.22 - $143.62 $13,778 - $15,080	-105 Reduced 0.36%	28,735 $4.02 Million
Q3 2017 Oct 18, 2017	BUY	$129.47 - $135.38 $3.73 Million - $3.9 Million	28,840	28,840 $3.75 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Johnson & Johnson Transaction History